Skip to main content
SpringerLink
Log in

Vaccines and the Cochlear Implant Patient

  • Chapter
  • First Online:
Book cover Pediatric Cochlear Implantation

  • 1792 Accesses

Abstract

Patients with cochlear implants should receive all the recommended routine vaccinations appropriate for age according to the Centers for Disease Control and Prevention (CDC) annual immunization schedule. These patients are at greater risk for the development of meningitis and other infections with Streptococcus pneumoniae, Haemophilus influenzae type b, and influenza viruses and CDC guidelines stress the importance of vaccination against these agents in these patients. This is especially true for infections caused by Streptococcus pneumoniae. Vaccination with pneumococcal vaccines, both conjugate and polysaccharide, is critically important in the prevention of pneumococcal disease in cochlear implant patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 139.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Agrawal A, Murphy TF. Haemophilus influenza infections in the H. influenzae Type b conjugate vaccine era. J Clin Micrbiol. 2011;49(11):3728–32.

    Article  CAS  Google Scholar 

  • Arnold W, Bredberg G, Gstottner W, Helms J, Hildmann H, Keratzidis T, et al. Meningitis following cochlear implantation: pathomechanisms, clinical symptoms, conservative and surgical treatments. Otorhinolaryngol Relat Spec. 2002;64:382–9.

    Google Scholar 

  • Biernath KR, Reefhuis J, Whitney CG, Mann EA, Costa P, Eichwald J, et al. Bacterial meningitis among children with cochlear implants beyond 24 months after implantation. Pediatrics. 2006;117(2):284–9.

    Google Scholar 

  • CDC. Licensure of a 13-valent pneumococcal conjugate vaccine (PCV13) and recommendations for use among children – Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Morb Mortal Wkly Rep. 2010;59(09):258–61.

    Google Scholar 

  • CDC. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine for adults with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2012;61:816–9.

    Google Scholar 

  • CDC. Use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine among children aged 6-18 years with immunocompromising conditions: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2013;62(25):521–4.

    Google Scholar 

  • CDC. Advisory committee on immunization practices recommended immunization schedules for persons aged 0 through 18 years – United States, 2014. MMWR Morb Mortal Wkly Rep. 2014a;63(05):108–9.

    Google Scholar 

  • CDC. Advisory committee on immunization practices recommended immunization schedule for adults aged 19 years or older – United States, 2014. MMWR Morb Mortal Wkly Rep. 2014b;63(5):110–2.

    Google Scholar 

  • CDC. Use of vaccines to prevent meningitis in persons with cochlear implants. www.cdc.gov/vaccines/vdp-vac/mening/cochlear/dis-cochlear-gen.htm

  • CDC. www.cdc.gov/vaccines/schedules

  • Cohen N, Ramos A, Ramsden R, Baumqarten W, Lesisnski A, O’donoghue G, et al. International consensus on meningitis and cochlear implants. Second meeting consensus on auditory implants, 19–21 February 2004, Valencia, Spain. Acta Otolaryngol. 2005;125:916–7.

    Google Scholar 

  • Cohen R, Levy C, Bingen E, Koskas M, Nave I, Varon E, et al. Impact of 13-valent pneumococcal conjugate vaccine on pneumococcal nasopharyngeal carriage in children with acute otitis media. Pediatr Infect Dis J. 2012;31(3):297–301.

    Google Scholar 

  • Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, et al. Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med. 2001;344:403–9.

    Google Scholar 

  • Gluth MB, Singh R, Atlas MD. Prevention and management of cochlear implant infections. Cochlear Implants Int. 2011;12(4):223–7.

    Article  PubMed  Google Scholar 

  • Govaerts PJ, De Beukelaer C, Daemers K, Deceulaer G, Yperman M, Somers T, et al. Outcome of cochlear implantation at different ages from 0 to 6 years. Otol Neurotol. 2002;23:885–90.

    Google Scholar 

  • Hansen S, Anthonsen K, Stangerup SE, Jensen JH, Thomsen J, Caye-Thomasen P. Unexpected findings and surgical complications in 505 consecutive cochlear implantations: a proposal for reporting consensus. Acta Otolaryngol. 2010;130:540–9.

    Google Scholar 

  • Hellingman CA, Dunnebier EA. Cochlear implantation in patients with acute or chronic middle ear infectious disease: a review of the literature. Eur Arch Otorhinolaryngol. 2009;266:171–6.

    Article  PubMed  Google Scholar 

  • Hopfenspirger MT, Levine SC, Rimell FL. Infectious complications in pediatric cochlear implants. Laryngoscope. 2007;117:1825–9.

    Article  PubMed  Google Scholar 

  • Loundon N, Blanchard M, Roger G, Denoyelle F, Garabedian EN. Medical and surgical complications in pediatric cochlear implantation. Arch Otolaryngol Head Neck Surg. 2010;136:12–5.

    Google Scholar 

  • Luntz M, Hodges AV, Balkany T, Dolan-Ash S, Schloffman J. Otitis media in children with cochlear implants. Laryngoscope. 1995;106:1403–5.

    Google Scholar 

  • Marom T, Tan A, Wilkinson GS, Pierson KS, Freeman JL, Chonmaitree T. Trends in otitis media-related health care utilization in the United States, 2001–2011. JAMA Pediatr. 2014;168(1):68–75.

    Google Scholar 

  • McJunkin J, Jeyakumar A. Complications in pediatric cochlear implants. Am J Otolaryngol Head Neck Med Surg. 2010;31:110–3.

    Google Scholar 

  • Nuorti JP, Whitney CG. Prevention of pneumococcal disease among infants and children – use of 13-valent pneumococcal conjugate vaccine and 23-valent pneumococcal polysaccharide vaccine. MMWR Morb Mortal Wkly Rep. 2010;59(11):1–18.

    Google Scholar 

  • Reefhuis J, Honein MA, Whitney CG, Chamany S, Mann Ea, Biernath KR, et al. Risk of bacterial meningitis in children with cochlear implants. N Engl J Med. 2003;349:435–45.

    Google Scholar 

  • Rubin LG, Papsin B, and the Committee on Infectious Diseases and Section on Otolaryngology-Head and Neck Surgery. and the committee on infectious diseases and section on otolaryngology-head and neck surgery. American Academy of Pediatrics Policy statement – cochlear implants in children: Surgical site infections and the prevention and treatment of acute otitis media and meningitis. Pediatrics. 2010;126:381–91.

    Article  PubMed  Google Scholar 

  • Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58(3):309–18.

    Google Scholar 

  • Wei BPC, Shepherd RK, Robins-Browne RM, Clark GM, O’Leary SJ. Pneumococcal meningitis post-cochlear implantation: preventative measures. Otolaryngol Head Neck Surg. 2010a;143:S9–14.

    Google Scholar 

  • Wei BPC, Shepherd RK, Robins-Browne RM, Clark GM, O’Leary SJ. Pneumococcal meningitis post-cochlear implantation: potential routes of infection and pathophysiology. Otolaryngol Head Neck Surg. 2010b;143:S15–23.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Pediatric Infectious Diseases, Ann & Robert H. Lurie Children’s Hospital, Box 20, 225 E. Chicago Ave, Chicago, 60611, IL, USA

    Tina Q. Tan M.D.

  2. Department of Pediatrics, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA

    Tina Q. Tan M.D.

Authors
  1. Tina Q. Tan M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Tina Q. Tan M.D. .

Editor information

Editors and Affiliations

  1. Section of Otology/Neurotology, Ann & Robert H Lurie Children’s Hospital Section of Otology/Neurotology, CHICAGO, Illinois, USA

    Nancy M Young

  2. Department of Speech and Hearing Science, Univ. of Illinois at Urbana-Champaign Department of Speech and Hearing Science, Champaign, Illinois, USA

    Karen Iler Kirk

Rights and permissions

Reprints and permissions

Copyright information

© 2016 Springer Science+Business Media LLC

About this chapter

Cite this chapter

Tan, T.Q. (2016). Vaccines and the Cochlear Implant Patient. In: Young, N., Iler Kirk, K. (eds) Pediatric Cochlear Implantation. Springer, New York, NY. https://doi.org/10.1007/978-1-4939-2788-3_3

Download citation

  • DOI: https://doi.org/10.1007/978-1-4939-2788-3_3

  • Published:

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4939-2787-6

  • Online ISBN: 978-1-4939-2788-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation